Pluristem Therapeutics  logo

Pluristem Therapeutics PSTI

report update icon

Quarterly report 2026-Q4
added 09-10-2026

Country

israelIsrael

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

Shares

9.74 M

Market Cap[1]

$ 33.3 M

EBITDA (LTM)

$ -25.4 M

P/E (LTM)

-

P/S (LTM)

37.908052

EPS (LTM)

-2.62

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
uniQure N.V. uniQure N.V.
QURE
$ 22.7 -0.39 % $ 1.31 B Nasdaq Global Select Market niderlandNiderland
Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical
RARE
$ 16.13 -1.71 % $ 1.59 B Nasdaq Global Select Market,SPB usaUSA
Rafael Holdings Rafael Holdings
RFL
$ 1.11 2.45 % $ 57 M NYSE usaUSA
REGENXBIO REGENXBIO
RGNX
$ 7.66 -5.08 % $ 395 M Nasdaq Global Select Market,SPB usaUSA
Rigel Pharmaceuticals Rigel Pharmaceuticals
RIGL
$ 43.83 4.22 % $ 788 M Nasdaq Global Select Market usaUSA
SELLAS Life Sciences Group SELLAS Life Sciences Group
SLS
$ 8.38 -2.39 % $ 914 M Nasdaq Capital Market usaUSA
Celsion Corporation Celsion Corporation
CLSN
- -6.63 % $ 13.9 M Nasdaq Capital Market usaUSA
Генетико Генетико
GECO
- - - MOEX russiaRussia
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Tenax Therapeutics Tenax Therapeutics
TENX
$ 1.69 -5.34 % $ 66.3 M Nasdaq Global Select Market usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M Nasdaq Global Market germanyGermany
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
- 0.74 % $ 768 M Nasdaq Capital Market israelIsrael
Abcam plc Abcam plc
ABCM
- - $ 4.9 B Nasdaq Global Select Market britainBritain
Rezolute Rezolute
RZLT
$ 4.01 3.83 % $ 417 M Nasdaq Capital Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Tiziana Life Sciences PLC Tiziana Life Sciences PLC
TLSA
$ 0.61 -8.44 % $ 65.1 M Nasdaq Global Market britainBritain
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Affimed N.V. Affimed N.V.
AFMD
- -34.95 % $ 21.5 M Nasdaq Global Select Market,SPB germanyGermany
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
- -1.58 % $ 28.1 M Nasdaq Global Market chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
- - $ 12.5 M Nasdaq Global Market belgiumBelgium
Seer Seer
SEER
$ 1.62 -3.57 % $ 89.7 M Nasdaq Global Select Market usaUSA
Gracell Biotechnologies Gracell Biotechnologies
GRCL
- - $ 3.37 B Nasdaq Global Select Market chinaChina
Shattuck Labs Shattuck Labs
STTK
$ 4.86 -2.71 % $ 338 M Nasdaq Global Select Market usaUSA
Silence Therapeutics plc Silence Therapeutics plc
SLN
$ 19.78 0.15 % $ 2.8 B Nasdaq Global Select Market britainBritain
Stoke Therapeutics Stoke Therapeutics
STOK
$ 27.16 -1.98 % $ 1.61 B Nasdaq Global Select Market,SPB usaUSA
Sutro Biopharma Sutro Biopharma
STRO
$ 10.08 -5.0 % $ 85.7 M Nasdaq Global Select Market usaUSA
Soligenix Soligenix
SNGX
$ 0.32 -6.35 % $ 1.66 M Nasdaq Capital Market usaUSA
Teva Pharmaceutical Industries Limited Teva Pharmaceutical Industries Limited
TEVA
$ 42.54 -1.0 % $ 48.7 B NYSE israelIsrael
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
$ 2.99 -3.55 % $ 2.03 M Nasdaq Global Select Market chinaChina
Spruce Biosciences Spruce Biosciences
SPRB
$ 46.36 -6.04 % $ 35.5 M Nasdaq Global Select Market usaUSA
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
TAK
$ 20.9 -0.9 % $ 33 B NYSE japanJapan
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
$ 28.77 4.15 % $ 1.62 B Nasdaq Global Select Market,SPB usaUSA
Galapagos NV Galapagos NV
GLPG
- - $ 1.83 B Nasdaq Global Select Market belgiumBelgium
Savara Savara
SVRA
$ 4.92 -2.57 % $ 1.09 B Nasdaq Global Select Market usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
- -13.85 % $ 16.1 M Nasdaq Global Select Market usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
- - $ 2.91 B Nasdaq Global Select Market usaUSA
TG Therapeutics TG Therapeutics
TGTX
$ 64.27 1.4 % $ 9.28 B Nasdaq Capital Market usaUSA
Aphria Inc. Aphria Inc.
APHA
- -0.45 % $ 4.87 B Nasdaq Global Select Market canadaCanada
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.
ARPO
- -0.90 % $ 104 M Nasdaq Capital Market usaUSA
Chiasma, Inc. Chiasma, Inc.
CHMA
- -6.00 % $ 238 M Nasdaq Global Select Market usaUSA
Trevi Therapeutics Trevi Therapeutics
TRVI
$ 14.92 -2.55 % $ 2.01 B Nasdaq Global Market usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
- - $ 376 M Nasdaq Global Market usaUSA
Cellect Biotechnology Ltd. Cellect Biotechnology Ltd.
APOP
- 0.38 % $ 12.9 M Nasdaq Global Select Market israelIsrael
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
AZRX
- 2.07 % $ 34.4 M Nasdaq Capital Market usaUSA
Cerecor Inc. Cerecor Inc.
CERC
- -1.68 % $ 283 M Nasdaq Capital Market usaUSA
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc.
CNST
- - $ 1.63 B Nasdaq Global Select Market usaUSA
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
- -1.77 % $ 39.2 M Nasdaq Capital Market bermudaBermuda

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.